{
  "ticker": "EW",
  "year": 2023,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 20,
  "transactions": [
    {
      "id": 181671,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-12-29",
      "transaction_shares": "14510.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33758.0000"
    },
    {
      "id": 181763,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-12-15",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 181743,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-12-13",
      "transaction_shares": "8000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "47502.6931"
    },
    {
      "id": 181752,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-12-13",
      "transaction_shares": "8658.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222451.7137"
    },
    {
      "id": 181768,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-12-13",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-12-06",
      "transaction_shares": "3500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "27450.0000"
    },
    {
      "id": 181736,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-11-13",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-11-13",
      "transaction_shares": "6000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "45502.6931"
    },
    {
      "id": 181741,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-11-03",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181694,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-10-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-10-13",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131926,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-10-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44502.6931"
    },
    {
      "id": 181679,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-10-13",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-10-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44502.6931"
    },
    {
      "id": 131868,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-10-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 181734,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-10-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 131909,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-10-03",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 181781,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-10-03",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 131811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181675,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    }
  ]
}